(By Anthony Miller – Tuesday 28th July 2009 8:00am). No revelations – positive or negative – in Sage’s IMS today (see here) – just a ‘steady as she goes’ as the company heads towards an ‘in line’ year end in September. CEO Paul Walker is “planning for markets to remain testing” and expects Sage to pass the test, that is, within the context of its first organic revenue decline reported at half-time (see Sage suffers organic revenue decline). No specific comments today on Sage’s Healthcare division, the erstwhile Emdeon Practice Services. I was rather hoping to hear positive news based on Misys’ upbeat assessment last week of the expected impact of Obama’s fiscal stimulus package (see Misys ‘shows and tells’). I still think optimism on this is overbaked but nonetheless, surely Sage should see some benefit. Anyway, we will undoubtedly hear more at year-end.
Tuesday, 28 July 2009
Sage expects ‘testing’ markets
(By Anthony Miller – Tuesday 28th July 2009 8:00am). No revelations – positive or negative – in Sage’s IMS today (see here) – just a ‘steady as she goes’ as the company heads towards an ‘in line’ year end in September. CEO Paul Walker is “planning for markets to remain testing” and expects Sage to pass the test, that is, within the context of its first organic revenue decline reported at half-time (see Sage suffers organic revenue decline). No specific comments today on Sage’s Healthcare division, the erstwhile Emdeon Practice Services. I was rather hoping to hear positive news based on Misys’ upbeat assessment last week of the expected impact of Obama’s fiscal stimulus package (see Misys ‘shows and tells’). I still think optimism on this is overbaked but nonetheless, surely Sage should see some benefit. Anyway, we will undoubtedly hear more at year-end.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment